Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology EPS Diluted (Quarterly) : -0.1138 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1138 |
| March 31, 2026 | -0.1161 |
| December 31, 2025 | -0.109 |
| September 30, 2025 | -0.1075 |
| June 30, 2025 | -0.1191 |
| March 31, 2025 | -0.1317 |
| December 31, 2024 | -0.1399 |
| September 30, 2024 | -0.1311 |
| June 30, 2024 | -0.1437 |
| March 31, 2024 | -0.1497 |
| December 31, 2023 | -0.1362 |
| September 30, 2023 | -0.1271 |
| June 30, 2023 | -0.1269 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.1201 |
| December 31, 2022 | -0.1074 |
| September 30, 2022 | -0.1128 |
| June 30, 2022 | -0.118 |
| March 31, 2022 | -0.1267 |
| December 31, 2021 | -0.1343 |
| September 30, 2021 | -0.1169 |
| June 30, 2021 | -0.1945 |
| March 31, 2021 | -0.0922 |
| December 31, 2020 | -0.1618 |
| September 30, 2020 | -0.1204 |
| June 30, 2020 | -0.119 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Harvard Bioscience, Inc. | -0.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.47M |
| Revenue (Quarterly) | 0.19M |
| Total Expenses (Quarterly) | 14.66M |
| Enterprise Value | 230.04M |
| Gross Profit Margin (Quarterly) | -583.7% |
| Profit Margin (Quarterly) | -7.62K% |
| Earnings Yield | -19.84% |
| Normalized Earnings Yield | -19.84 |